Trials / Completed
CompletedNCT02052167
Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
Human Factors Study for the Evaluation of the Methotrexate Prefilled Pen (50 mg/mL) for Subcutaneous Injection in Pediatric and Adolescent Patients With Juvenile Idiopathic Arthritis
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- medac GmbH · Industry
- Sex
- All
- Age
- 2 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is planned to evaluate the human factor (HF)/usability of pediatric or adolescent JIA patients and the caregivers of Juvenile Idiopathic Arthritis (JIA) patients with the Methotrexate Prefilled Pen (including a label comprehension assessment and a device robustness evaluation).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | methotrexate prefilled pen |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-01-31
- Last updated
- 2018-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02052167. Inclusion in this directory is not an endorsement.